News for hackers. Stuff that matters.
Re:Ketamine has 'fast-acting benefits' for depression by tibuma on Monday April 16, 2018 @05:31AM (#16847731)
> Pharma companies don't benefit from getting Ketamine approved (since it's no longer patent protected), so no one is putting it through FDA for depression.

This is incorrect.

There are ongoing phase 3 clinical trials for nasally applied esketamine that will lead to FDA approval if succesfully reviewed. These trials are conducted worldwide and are very encouraging. The specific application seems to be patentable. First results should be available around 2019ish or 2020.

You can find the trials here:

https://clinicaltrials.gov/ct2/results?term=esketamine+depre...

And one of the patent applications here:

https://patents.google.com/patent/US20130236573A1

Re:Ketamine has 'fast-acting benefits' for depression by shawnz on Monday April 16, 2018 @08:31AM (#16848455)
> This is incorrect. There are ongoing phase 3 clinical trials for nasally applied esketamine that will lead to FDA approval if succesfully reviewed.

Specifically esketamine, not ketamine, because focusing on this specific isomer was the only way to get a new patent.

What if racemic ketamine performs better than esketamine? We'll never know because they won't test that.

Re:Ketamine has 'fast-acting benefits' for depression by tibuma on Monday April 16, 2018 @11:34AM (#16849651)
> What if racemic ketamine performs better than esketamine? We'll never know because they won't test that.

It's quite likely some public institutions (e.g., universities, public research labs, etc.) or other countries (e.g., in India, China) will test exactly that. It's also in their interest to pubblish the results. So we'll get to know the differences between racemic ketamine, esketamine and arketamine.

The question is if different variants will also be approved, which is much more expensive.

Re:Ketamine has 'fast-acting benefits' for depression by TTPrograms on Monday April 16, 2018 @10:47AM (#16849319)
Racemic ketamine is also dirt cheap, while esketamine might be absurdly expensive after being patented.
Re:Ketamine has 'fast-acting benefits' for depression by jeffreyrogers on Monday April 16, 2018 @10:23AM (#16849181)
Do you have a source for that? You can get a patent on a new use for something that already exists if the new use is a non-obvious advance over the prior art.